Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Daneshmanesh · SciRah

Researcher profile · Semantic Scholar

A. Daneshmanesh

Share profile

A. Daneshmanesh — researcher profile on SciRah

h-index: 8
Works: 24
Citations: 469

Most-cited papers

The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.
M. Hojjat-Farsangi, A. Moshfegh, A. Daneshmanesh, Abdul Salam Khan +3 more
2014Seminars in Cancer Biology94 citations
Semantic Scholar
Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies
A. Daneshmanesh, A. Porwit, M. Hojjat-Farsangi, M. Jeddi-Tehrani +8 more
2013Leukemia and Lymphoma88 citations Open access
Semantic Scholar
Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
M. Hojjat-Farsangi, F. Ghaemimanesh, A. Daneshmanesh, A. Bayat +4 more
2013PLoS ONE64 citations Open access
Semantic Scholar
The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
M. Hojjat-Farsangi, Abdul Salam Khan, A. Daneshmanesh, A. Moshfegh +6 more
2013PLoS ONE62 citations Open access
Semantic Scholar
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib
A. Daneshmanesh, M. Hojjat-Farsangi, Amineh Ghaderi, A. Moshfegh +8 more
2018PLoS ONE42 citations Open access
Semantic Scholar
ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
Amineh Ghaderi, A. Daneshmanesh, A. Moshfegh, P. Kokhaei +10 more
2020Biomedicines37 citations Open access
Semantic Scholar
Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia
Abdul Salam Khan, M. Hojjat-Farsangi, A. Daneshmanesh, L. Hansson +4 more
2016Tumor Biology30 citations
Semantic Scholar
Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia
M. Hojjat-Farsangi, M. Jeddi-Tehrani, A. Daneshmanesh, F. Mozaffari +8 more
2015PLoS ONE15 citations Open access
Semantic Scholar
Diffuse Large B Cell Lymphoma (DLBCL) Expresses ROR1 and a ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Tumor Cells
M. Hojjat-Farsangi, Amineh Ghaderi, A. Daneshmanesh, Jemina Lehto +13 more
2019Blood6 citations Open access
Semantic Scholar
First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL Cells
M. Hojjat-Farsangi, A. Moshfegh, A. Daneshmanesh, J. Vågberg +9 more
20155 citations
Semantic Scholar
Abstract 4770: Anti-ROR1 monoclonal antibodies induce apoptosis in pancreatic cancer cells via the PI3-kinase/AKT/mTOR pathway
A. Daneshmanesh, M. Hojjat-Farsangi, A. Moshfegh, Eva Mikaelsson +3 more
20145 citations
Semantic Scholar
A new class of compound for pancreatic carcinoma targeting the tyrosine kinase receptor (TKR) ROR1.
H. Mellstedt, A. Daneshmanesh, A. Moshfegh, M. Farsangi +7 more
20144 citations
Semantic Scholar
First generation of a small chemical molecule ROR1 RTK tyrosine kinase inhibitor
H. Mellstedt, M. Hojjat-Farsangi, A. Daneshmanesh, A. Moshfegh +6 more
20163 citations Open access
Semantic Scholar
A new class of anti-cancer drugs targeting the tyrosine kinase receptor ROR1 in CLL.
H. Mellstedt, Salam Khan, M. Hojjat-Farsangi, A. Daneshmanesh +10 more
20153 citations
Semantic Scholar
Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)
M. Hojjat-Farsangi, F. Mozaffari, A. Daneshmanesh, A. Österborg +2 more
20113 citations
Semantic Scholar
Ror1 Targeting Monoclonal Antibodies Induced Apoptosis of Chronic Lymphocytic Leukemia Cells– A Potential Novel Therapeutic Approach
H. Rabbani, A. Daneshmanesh, Abdul Salam Khan, M. Hojjat-Farsangi +5 more
20103 citations
Semantic Scholar
Apoptosis induction mediated through PI3-kinase/AKT/mTOR pathway using anti-ROR1 monoclonal antibody in chronic lymphocytic leukemia cells.
A. Daneshmanesh, M. Farsangi, A. Moshfegh, Salam Khan +2 more
20132 citations
Semantic Scholar
T Cells From CLL Patients Recognize Spontaneously Peptides Derived of the Receptor Tyrosine Kinase Ror1
M. Farsangi, A. Daneshmanesh, M. Jeddi-Tehrani, A. Österborg +3 more
20102 citations
Semantic Scholar
First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells
M. Hojjat-Farsangi, A. Daneshmanesh, F. Mozaffari, L. Hansson +11 more
20171 citations
Semantic Scholar
Monoclonal Antibody Against ROR1 in Chronic Lymphocytic Leukemia Cells Induced Apoptosis Via PI3-Kinase/AKT/CREB Pathway
A. Daneshmanesh, M. Hojjat-Farsangi, Åsa Sandin, Abdul Salam Khan +4 more
20121 citations
Semantic Scholar
Phosphorylation of Receptor Tyrosine Kinase ROR1 At Tyrosine 641, 646 and Serine 652 residues Might Be of Importance for the Survival of CLL Leukemic Cells
M. Hojjat-Farsangi, A. Daneshmanesh, M. Norin, Åsa Sandin +5 more
20121 citations
Semantic Scholar
ROR1-a Novel Receptor Tyrosine Kinase with Unique Therapeutic Potentials in Chronic Lymphocytic Leukemia
A. Daneshmanesh
20110 citations
Semantic Scholar
Patologi ROR 1-a Novel Receptor Tyrosine Kinase with Unique Therapeutic Potentials in Chronic Lymphocytic Leukemia
A. Daneshmanesh
20110 citations
Semantic Scholar
ROR 1-a Novel Receptor Tyrosine Kinase with Unique Therapeutic Potentials in Chronic Lymphocytic Leukemia
A. Daneshmanesh
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Mellstedt×20
Invite
H. Mellstedt — researcher profile on SciRah
A. Österborg×19
Invite
A. Österborg — researcher profile on SciRah
M. Hojjat-Farsangi×18
Invite
M. Hojjat-Farsangi — researcher profile on SciRah
A. Moshfegh×16
Invite
A. Moshfegh — researcher profile on SciRah

×8

Invite

J. Schultz — researcher profile on SciRah

Invite

T. Olin — researcher profile on SciRah

Abdul Salam Khan×7

Invite

Abdul Salam Khan — researcher profile on SciRah

Invite

J. Vågberg — researcher profile on SciRah

M. Jeddi-Tehrani×6

Invite

M. Jeddi-Tehrani — researcher profile on SciRah

Invite

F. Shokri — researcher profile on SciRah

Invite

S. Byström — researcher profile on SciRah

Invite

E. Olsson — researcher profile on SciRah